Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Diamant

Showing results (141-150 of 212) with videos related to

Pageof 22
Sort By:
Diabetes|March 23, 2012
Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variablesEelco van Duinkerken, Menno M Schoonheim, Ernesto J Sanz-Arigita, et al.
Diabetologia|April 3, 2016
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trialLennart Tonneijck, Mark M Smits, Marcel H A Muskiet, et al.
Diabetes, Obesity & Metabolism|April 28, 2017
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trialLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Diabetes Care|February 28, 2004
The relationship of lipoprotein lipase activity and LDL size is dependent on glucose metabolism in an elderly population: the Hoorn StudyGriët Bos, Peter G Scheffer, Delfina Vieira, et al.
European Journal of Endocrinology|July 29, 2016
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trialDaniël H van Raalte, Mathijs C Bunck, Mark M Smits, et al.
European Journal of Endocrinology|February 4, 2010
Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy menDaniël H van Raalte, Valentina Nofrate, Mathijs C Bunck, et al.
European Journal of Endocrinology|January 15, 2014
The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetesDaniël H Van Raalte, Renate E van Genugten, Björn Eliasson, et al.
Cellular Signalling|June 22, 2011
Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cellsMargot M L Linssen, Daniel H van Raalte, Erik J M Toonen, et al.
European Journal of Heart Failure|July 30, 2010
Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn StudyKatja van den Hurk, Marjan Alssema, Otto Kamp, et al.
Diabetes, Obesity & Metabolism|July 25, 2016
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patientsMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Diabetes|March 23, 2012
Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variablesEelco van Duinkerken, Menno M Schoonheim, Ernesto J Sanz-Arigita, et al.
Diabetologia|April 3, 2016
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trialLennart Tonneijck, Mark M Smits, Marcel H A Muskiet, et al.
Diabetes, Obesity & Metabolism|April 28, 2017
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trialLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Diabetes Care|February 28, 2004
The relationship of lipoprotein lipase activity and LDL size is dependent on glucose metabolism in an elderly population: the Hoorn StudyGriët Bos, Peter G Scheffer, Delfina Vieira, et al.
European Journal of Endocrinology|July 29, 2016
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trialDaniël H van Raalte, Mathijs C Bunck, Mark M Smits, et al.
European Journal of Endocrinology|February 4, 2010
Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy menDaniël H van Raalte, Valentina Nofrate, Mathijs C Bunck, et al.
European Journal of Endocrinology|January 15, 2014
The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetesDaniël H Van Raalte, Renate E van Genugten, Björn Eliasson, et al.
Cellular Signalling|June 22, 2011
Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cellsMargot M L Linssen, Daniel H van Raalte, Erik J M Toonen, et al.
European Journal of Heart Failure|July 30, 2010
Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn StudyKatja van den Hurk, Marjan Alssema, Otto Kamp, et al.
Diabetes, Obesity & Metabolism|July 25, 2016
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patientsMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Pageof 22